ENS-002

ENS-002 · Concerto Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ENS-002, covering 2025-08-14 to 2025-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Topical ENS-002 for Atopic Dermatitis in Adults [Phase 1]